Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Solid Biosciences (SLDB) Shares Outstanding (Weighted Average): 2017-2024

Historic Shares Outstanding (Weighted Average) for Solid Biosciences (SLDB) over the last 8 years, with Dec 2024 value amounting to $40.0 million.

  • Solid Biosciences' Shares Outstanding (Weighted Average) rose 98.02% to $40.0 million in Q4 2024 from the same period last year, while for Sep 2024 it was $38.6 million, marking a year-over-year increase of 92.40%. This contributed to the annual value of $40.0 million for FY2024, which is 98.02% up from last year.
  • As of FY2024, Solid Biosciences' Shares Outstanding (Weighted Average) stood at $40.0 million, which was up 98.02% from $20.2 million recorded in FY2023.
  • In the past 5 years, Solid Biosciences' Shares Outstanding (Weighted Average) registered a high of $40.0 million during FY2024, and its lowest value of $4.0 million during FY2020.
  • Over the past 3 years, Solid Biosciences' median Shares Outstanding (Weighted Average) value was $20.2 million (recorded in 2023), while the average stood at $22.6 million.
  • Data for Solid Biosciences' Shares Outstanding (Weighted Average) shows a peak YoY soared of 167.79% (in 2023) over the last 5 years.
  • Over the past 5 years, Solid Biosciences' Shares Outstanding (Weighted Average) (Yearly) stood at $4.0 million in 2020, then surged by 82.46% to $7.4 million in 2021, then increased by 2.47% to $7.5 million in 2022, then skyrocketed by 167.79% to $20.2 million in 2023, then skyrocketed by 98.02% to $40.0 million in 2024.